Antibody Manufacture in Transgenic Animals and Comparisons with Other Systems

Overview

Journal Curr Opin Biotechnol

Publisher Elsevier

Specialty Biotechnology

Date 2002 Dec 17

PMID 12482525

Citations 18

Authors

Louis Marie Houdebine

Affiliations

Soon will be listed here.

Abstract

Various forms of recombinant monoclonal antibodies are being used increasingly, mainly for therapeutic purposes. The isolation and engineering of the corresponding genes is becoming less of a bottleneck in the process; however, the production of recombinant antibodies is itself a limiting factor and a shortage is expected in the coming years. Milk from transgenic animals appears to be one of the most attractive sources of recombinant antibodies. None of the production systems presently implemented (CHO cells, insect cells infected by baculovirus, or transgenic animals and plants) has yet been optimized. This review describes the advantages of using milk for antibody production in comparison with the other systems.

Citing Articles

Genetically modified chickens as bioreactors for protein-based drugs.

Meng S, Miao A, Wu S, Du X, Gao F Front Genome Ed. 2025; 6():1522837.

PMID: 39845893 PMC: 11753250. DOI: 10.3389/fgeed.2024.1522837.

Development of a Mucus Gland Bioreactor in Loach .

Zhou T, Zhou B, Zhao Y, Li Q, Song G, Zhu Z Int J Mol Sci. 2021; 22(2).

PMID: 33445609 PMC: 7827776. DOI: 10.3390/ijms22020687.

A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle.

Zhang R, Tang C, Guo H, Tang B, Hou S, Zhao L Sci Rep. 2018; 8(1):13208.

PMID: 30181542 PMC: 6123398. DOI: 10.1038/s41598-018-31417-2.

The transgenic animal platform for biopharmaceutical production.

Bertolini L, Meade H, Lazzarotto C, Martins L, Tavares K, Bertolini M Transgenic Res. 2016; 25(3):329-43.

PMID: 26820414 DOI: 10.1007/s11248-016-9933-9.

Expression of recombinant vaccines and antibodies in plants.

Ko K Monoclon Antib Immunodiagn Immunother. 2014; 33(3):192-8.

PMID: 24937251 PMC: 4063376. DOI: 10.1089/mab.2014.0049.

References

Berdoz J, Blanc C, Reinhardt M, Kraehenbuhl J, Corthesy B . In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci U S A. 1999; 96(6):3029-34. PMC: 15889. DOI: 10.1073/pnas.96.6.3029. View

Weidle U, Lenz H, Brem G . Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene. 1991; 98(2):185-91. DOI: 10.1016/0378-1119(91)90172-8. View

Ferrantelli F, Ruprecht R . Neutralizing antibodies against HIV -- back in the major leagues?. Curr Opin Immunol. 2002; 14(4):495-502. DOI: 10.1016/s0952-7915(02)00362-x. View

Malassagne B, Viglietta C, Puissant C, Chereau C, Attal J, Weill B . Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits. Transgenic Res. 1999; 8(3):223-35. DOI: 10.1023/a:1008919925303. View

Sola I, Castilla J, Pintado B, Whitelaw C, Clark A, Enjuanes L . Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virol. 1998; 72(5):3762-72. PMC: 109598. DOI: 10.1128/JVI.72.5.3762-3772.1998. View

Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey J . Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol. 1999; 17(2):176-80. DOI: 10.1038/6179. View

Heppner F, Musahl C, Arrighi I, Klein M, Rulicke T, Oesch B . Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science. 2001; 294(5540):178-82. DOI: 10.1126/science.1063093. View

Casadevall A . Antibodies for defense against biological attack. Nat Biotechnol. 2002; 20(2):114. DOI: 10.1038/nbt0202-114. View

Tomizuka K, Yoshida H, Uejima H, Kugoh H, Sato K, Ohguma A . Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet. 1997; 16(2):133-43. DOI: 10.1038/ng0697-133. View

10.

Gura T . Therapeutic antibodies: magic bullets hit the target. Nature. 2002; 417(6889):584-6. DOI: 10.1038/417584a. View

11.

Fletcher M, Kuderova A, Cygler M, Lee J . Creation of a ribonuclease abzyme through site-directed mutagenesis. Nat Biotechnol. 1998; 16(11):1065-7. DOI: 10.1038/3519. View

12.

Chargelegue D, Vine N, van Dolleweerd C, Drake P, Ma J . A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res. 2000; 9(3):187-94. DOI: 10.1023/a:1008976219939. View

13.

Stinnakre M, Soulier S, Schibler L, Lepourry L, Mercier J, Vilotte J . Position-independent and copy-number-related expression of a goat bacterial artificial chromosome alpha-lactalbumin gene in transgenic mice. Biochem J. 1999; 339 ( Pt 1):33-6. PMC: 1220124. View

14.

De Groot N, Hooijberg E, DE BOER H . Expression of a functional mouse-human chimeric anti-CD19 antibody in the milk of transgenic mice. Transgenic Res. 2000; 9(2):155-9. PMC: 7089348. DOI: 10.1023/a:1008987403484. View

15.

Andersen D, Krummen L . Recombinant protein expression for therapeutic applications. Curr Opin Biotechnol. 2002; 13(2):117-23. DOI: 10.1016/s0958-1669(02)00300-2. View

16.

Houdebine L . Transgenic animal bioreactors. Transgenic Res. 2000; 9(4-5):305-20. PMC: 7089244. DOI: 10.1023/a:1008934912555. View

17.

Bouquin T, Thomsen M, Nielsen L, Green T, Mundy J, Dziegiel M . Human anti-rhesus D IgG1 antibody produced in transgenic plants. Transgenic Res. 2002; 11(2):115-22. DOI: 10.1023/a:1015226418688. View

18.

Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M . Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol. 1999; 17(11):1116-21. DOI: 10.1038/15104. View

19.

Ma J, Hikmat B, Wycoff K, Vine N, Chargelegue D, Yu L . Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med. 1998; 4(5):601-6. DOI: 10.1038/nm0598-601. View

20.

Lubon H . Transgenic animal bioreactors in biotechnology and production of blood proteins. Biotechnol Annu Rev. 1999; 4:1-54. DOI: 10.1016/s1387-2656(08)70066-8. View